Not Yet Recruiting
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
NCT07722546
- Conditions
- Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
- Locations
-
Not specified